Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial

on behalf of the AIEOP-BFM (Associazione Italiana di Ematologia e Oncologia Pediatrica & Berlin-Frankfurt-Münster) Study Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Publication statusE-pub ahead of print - Dec 5 2019

Cite this